Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-dose, Randomized, Open-label, Parallel-arm, Comparative Pharmacokinetic and Safety Study of Proposed Abatacept Biosimilar DRL_AB Administered by the Subcutaneous Route Via Autoinjector or Prefilled Syringe to Normal, Healthy, Male Participants

NCT07744828 is registered in ClinicalTrials.gov with Dr. Reddy's Laboratories Limited as lead sponsor.

NCT NCT07744828
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07744828 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-dose, Randomized, Open-label, Parallel-arm, Comparative Pharmacokinetic and Safety Study of Proposed Abatacept Biosimilar DRL_AB Administered by the Subcutaneous Route Via Autoinjector or Prefilled Syringe to Normal, Healthy, Male Participants
Lead sponsor
Dr. Reddy's Laboratories Limited
Phase
Phase 1
Overall status
Not yet recruiting
Start date
August 19, 2026
Completion date
December 29, 2026
Enrollment
160 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteers